Ultimately, on January 1st, 2024, the North Carolina State Health Plan made the decision to exclude GLP-1s for weight loss from coverage, while grandfathering in current utilizers
They slow gastric emptying, reduce appetite, and signal fullness to the brain
Additionally, a genetic predisposition also increases the risk for the eye disease, though experts dont fully understand this connection
For this reason, our focus remains on options that work within the bodys natural regulatory systems
A previous meta-analysis, including 5 RCTs and 6 non-RCTs, investigated the efficacy and safety of GLP-1RA/SGLT-2i combination therapy in T2DM or obesity (Guo et al., 2020), and demonstrated that the risk for cardiovascular events (including myocardial infarction, stroke and heart failure hospitalization) was lower with combination therapy
Women using HRT/laser/O-shot: Complements for holistic results